PACB - Pacific Bioscie Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 XLF (0%) F (0%) AAPL (1.61%) APPS (0%) BTCUSD (%) FUTU (0%) NDAQ (0%) REGI (0%) SPWR (0%) XSPA (0%) EVGN (0%) ETSY (0%) ETHUSD (%) ENDP (0%) ELY (0%) DQ (0%) DGLY (0%) DFS (0%) DAR (0%) DAL (0%) CVET (0%) CRSP (0%) COWN (0%) CELH (0%) BIOL (0%)

Recommendation

Service : FEAT. ANDRE 3000 | Trader : JOHN KROLIKOWSKI JR | Trade Date : 11/13/20

$PACB - Pacific Biosciences of California

Buy Long

Trade

87.68 %

Target

$17.05

Issue Price

$32.00

Target Price

11/13/21

Target Date

$8.99

Stop Loss

Trade Closed - WINNER

Hit Target Price

Reason

84.64 %

P/L %

$31.48

Close Price

55

Days Held

01/07/21

Closed Date

To view trade details and get more recommendations from this trader Subscribe

PACB - Pacific Biosciences ...

$37.42 1.11[3.06%]

15 mins delayed data

People also watch : TMO | FLDM | ILMN | PKI | LMNX | NSTG

+Watchlist

6 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$37.42	Open
Volume	18.8K	Market Cap	6.544B
Yield		Last Dividend

Day

52 Week

DNA Sequencing Market Growth Drivers, Tr...	01/21/21
(Jan 2021 trend research report ) Latest research report on Market 2020 DNA Sequencing published by insightSLICE, starts with the market description, ...

Global Next Generation Sequencing Market...	01/14/21
DUBLIN--(BUSINESS WIRE)--The "Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery" report has ...

Why Pacific Biosciences's Stock is Tradi...	01/13/21
Pacific Biosciences's Stock Price And Volume Action Pacific Biosciences's (NASDAQ:PACB) stock has been rising Wednesday, up 6.84% to a price of ???

Pacific Biosciences of California, Inc. ...	01/11/21
MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) ??? Pacific Biosciences of California, Inc. (the ???Company???) (NASDAQ: PACB), a leading provider ...

The Best Stock Picker of 2020 Wins With ...	12/31/20
(Bloomberg Opinion) -- Everyone should know Cathie Wood by now.That's because whatever benefits central bankers bequeathed to shareholders with next-t...

The Daily Biotech Pulse: FDA Nod For Amp...	12/29/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl...

Michael Hunkapiller Sells 335,549 Shares...	12/25/20
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 335,549 shares of Pacific Biosciences of California stock in a...

Watch Out, Pacific Biosciences Stock Is ...	12/09/20
Pacific Biosciences (PACB) Stock Is Very Extended???PACB

Digital Genome Market Analysis by Potent...	11/27/20
Engaged in development of digital genome, owing to greater future prospects of digital genome in the detection of chronic and infectious disease, birt...

This Is What Hedge Funds Bought And Sold...	11/16/20
This Is What Hedge Funds Bought And Sold In Q3: Complete 13F Summary Tyler Durden Mon, 11/16/2020 - 22:20 While we live in a time when the holdings of...

The Daily Biotech Pulse: Urovant In M&A ...	11/13/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) ALX...

Pacific Biosciences of California prices...	11/11/20
Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M...

Pacific Biosciences of California (NASDA...	10/24/20
Pacific Biosciences of California (NASDAQ:PACB) shares shot up 5.2% during mid-day trading on Thursday . The stock traded as high as $13.86 and last t...

$20.40 Million in Sales Expected for Pac...	10/23/20
Analysts forecast that Pacific Biosciences of California (NASDAQ:PACB) will announce $20.40 million in sales for the current fiscal quarter, Zacks Inv...

Pacific Biosciences of California (NASDA...	10/22/20
Shares of Pacific Biosciences of California (NASDAQ:PACB) were up 5.2% on Thursday . The company traded as high as $13.86 and last traded at $13.77. A...

Pacific Biosciences of California (NASDA...	10/20/20
Shares of Pacific Biosciences of California (NASDAQ:PACB) traded down 9.2% on Tuesday . The stock traded as low as $13.53 and last traded at $13.58. 7...

Pacific Biosciences (PACB) Up 8.1% Since...	06/05/20
Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pacific Biosciences (PACB) Q1 Earnings S...	05/08/20
Pacific Biosciences (PACB) saw revenue growth in the Service and Other segment in Q1.

Will Pacific Biosciences of California (...	04/29/20
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get pre...

Pacific Biosciences of California (PACB)...	04/24/20
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get pre...

Pacific Biosciences' Sequel II Gets Acqu...	04/21/20
Pacific Biosciences' (PACB) new development is likely to boost the company's flagship platform, the Sequel system.

Why Is Pacific Biosciences (PACB) Down 1...	03/07/20
Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Daily Biotech Pulse: Gilead Kicks Of...	02/27/20
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o...

The Daily Biotech Pulse: Moderna Ships C...	02/25/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) ...

The Daily Biotech Pulse: LogicBio Slappe...	02/11/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) ...

Pacific Biosciences (PACB) Reports Break...	02/07/20
Pacific Biosciences (PACB) expects softness in first-quarter consumable sales.

Pacific Biosciences of California (PACB)...	01/30/20
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get pre...

Pacific Biosciences of California, Inc. ...	01/21/20
MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call t...

Health Care Shares Fall as Deal News Sta...	01/03/20
Health-care companies fell as deal news remained in focus. Illumina called off its plans to buy Pacific Biosciences of California. The companies said ...

Illumina and Pacific Biosciences Announc...	01/02/20
SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announce...

ANALYST RATINGS

4 analyst ratings (Last 3 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	11/04/20
Morgan Stanley maintains Equal-Weight rating and raises Price Target from $7.00 to $12.00

EARNINGS

Date	2020-11-02 (AMC)	Est. (EPS/Rev.)	($0.13)/ 20.35M
Actual (EPS/Rev.)	$-0.14/ $19.08 M	EPS (TTM)	0

TRADERS TRACKING $PACB

Service Name	Trader	% Success
FEAT. ANDRE 3000	JOHN KROLIKOWSKI JR	89.00 %	Subscribe
Spread Hacker	MrToptick	86.00 %	Follow
WIDE AWAKE	JOHN KROLIKOWSKI JR	80.00 %	Follow
Option short-term trading [Unusual]	Debashis K	66.00 %	Subscribe
FEAT. MARVIN GAYE	JOHN KROLIKOWSKI JR	62.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.